Yen-Chun Liu

10PUBLICATIONS
14CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Haematological tumoursBehavioural epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 01, 2026
Letter: Dynamic HBcrAg and HBsAg After Nucleos(t)ide Analogue Cessation: Considerations in Interpreting Predictive Performance.

|Sep 28, 2024
Hepatocellular Carcinoma Incidences and Risk Factors in Hepatitis C Patients: Interferon versus Direct-Acting Agents.

Yu-Ting Kao, Yen-Chun Liu, Ya-Ting Cheng

|Jan 18, 2024
Higher end-of-treatment HBsAg levels is associated with later onset but not severe relapse in HBeAg-negative chronic hepatitis B patients stopping antivirals.

Yen-Chun Liu, Wen-Juei Jeng, Chien-Wei Peng

|Sep 13, 2023
Letter: Safety after cessation of nucleos(t)ide analogue therapy in patients with chronic hepatitis B infection.

Yen-Chun Liu, Wen-Juei Jeng, Rong-Nan Chien

|Aug 25, 2023
Hepatocellular carcinoma reduced, HBsAg loss increased, and survival improved after finite therapy in hepatitis B patients with cirrhosis.

Wen-Juei Jeng, Rong-Nan Chien, Yi-Cheng Chen

|Feb 14, 2023
Editorial: considerations for expanding treatment in grey zone chronic hepatitis B patients.

Yen-Chun Liu, Wen-Juei Jeng

Pageof 2

Frequent Collaborators

10 joint publications

Wen-Juei Jeng

3 joint publications

Chien-Wei Peng

3 joint publications

Rong-Nan Chien

2 joint publications

Yun-Fan Liaw